SuanFarma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SuanFarma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10803
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SuanFarma SA (SuanFarma Group) is a drug development company that offers production, development, and marketing of raw materials and finished dosage forms. The company’s products portfolio includes amoxiciline capsules, enalapril tablets, colistin methanesulphonate, azitromicine film coated tablet, and summum propol, among others. It also provides ironkit, generics services, OTC, baby food, veterinary, plameca, APIs, oncosuan, cidqo, dermotological products; and biotech and development and manufacturing services. SuanFarma Group offers drug development and manufacturing services such as analytical development, stabilities, galenic development, formulation and pilot batches, among others. The company caters to biotechnological, veterinary, pharmaceutical, nutritional and cosmetic sectors. SuanFarma Group is headquartered in Alcobendas, Spain.

SuanFarma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SuanFarma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SuanFarma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SuanFarma SA, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Intermediate Capital Group Acquires SuanFarma from ProA Capital 10
Equity Offering 11
Idifarma Desarrollo Farmaceutico Secures Investment from Suanfarma 11
Acquisition 12
Lusosuan Acquires 4.76% Stake in CIPAN 12
Suanfarma Acquires CIPAN 13
SuanFarma SA – Key Competitors 14
SuanFarma SA – Key Employees 15
SuanFarma SA – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
SuanFarma SA, Pharmaceuticals & Healthcare, Key Facts 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SuanFarma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SuanFarma SA, Deals By Therapy Area, 2012 to YTD 2018 8
SuanFarma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Intermediate Capital Group Acquires SuanFarma from ProA Capital 10
Idifarma Desarrollo Farmaceutico Secures Investment from Suanfarma 11
Lusosuan Acquires 4.76% Stake in CIPAN 12
Suanfarma Acquires CIPAN 13
SuanFarma SA, Key Competitors 14
SuanFarma SA, Key Employees 15
SuanFarma SA, Other Locations 16
SuanFarma SA, Subsidiaries 16

List of Figures
SuanFarma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SuanFarma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SuanFarma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SuanFarma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abbott Laboratories (ABT):企業の財務及び戦略的SWOT分析
    Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China Medical System Holdings Ltd (867):企業の財務・戦略的SWOT分析
    Summary China Medical System Holdings Ltd (CMS) is a pharmaceutical service provider that markets, promotes, and sells prescription drugs to all therapeutic departments in hospitals. The company offers products such as deanxit, ursofalk, augentropfen stulln mono eye-drops, exacin, xinhuosu, salofalk …
  • Thai Airways International Public Co Ltd:企業の戦略・SWOT・財務情報
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Veropharm (VRPH):企業概要、財務及び戦略的SWOT分析
    Summary Veropharm is a pharmaceutical company. The company develops and manufactures generic pharmaceutical drugs, oncological medications, and medical adhesive bandages. It operates through three plants, such as Voronezh Chemical-Pharmaceutical Plant, Belgorod and Basil plant, and Pokrov ready-made …
  • Treet Corporation Ltd:企業の戦略・SWOT・財務情報
    Treet Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Treet Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Universal Forest Products, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Universal Forest Products, Inc. …
  • French National Institute of Health and Medical Research:企業のM&A・提携動向(医療機器分野)
    Summary French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in therapeutic areas such as neurosciences, sciences, neurology, psychiatry, cancer, genetics, can …
  • Belo Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Belo Corp. Mergers and Acquisit …
  • Nikon Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Nikon Corporation Mergers and A …
  • Mayne Pharma Group Ltd (MYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly HalcyGen Pharmaceuticals Ltd, a subsidiary of Mayne Pharma Group Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise erymax capsules, kapanol capsules, …
  • Mainova AG (MNV6):企業のM&A・提携動向(発電分野)
    Summary Mainova AG (Mainova) is an energy service provider that supplies electricity, natural gas, heat and water. The utility’s services include energy and environmental awareness, energy contracting, energy efficiency, power plant service, elevator service, studies and consulting. It offers energy …
  • HoMedics, LLC.:企業の戦略的SWOT分析
    HoMedics, LLC. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Bristol-Myers Squibb Company (BMY):企業のM&A・提携動向(医療機器分野)
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company, which focuses on innovative drugs to address unmet medical needs of patients with serious diseases. It discovers, develops, licenses, manufactures, markets and distributes biopharmaceuticals and related healthcare pro …
  • Oversea-Chinese Banking Corporation Ltd:戦略・SWOT・企業財務分析
    Oversea-Chinese Banking Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Oversea-Chinese Banking Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Sucrerie Couplet SA:企業の戦略・SWOT・財務情報
    Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report Summary Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Esprit Holdings Limited:戦略・SWOT・企業財務分析
    Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Topchoice Medical Investment Co Ltd (600763):企業財務及び戦略的SWOT分析
    Summary Topchoice Medical Investment Co Ltd (Topchoice Medical) is a healthcare management center that provides investment services. The center offers services which include medical investment, hospital management, oral health care and medical care services. It provides transition to the business ar …
  • GoPro, Inc.:戦略・SWOT・企業財務分析
    GoPro, Inc. - Strategy, SWOT and Corporate Finance Report Summary GoPro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Shire Plc (SHP):企業のM&A・提携動向(医療機器分野)
    Summary Shire Plc (Shire) is a specialty biopharmaceutical company, which focuses on the research, development and commercialization of specialty pharmaceutical products for rare diseases and other serious conditions. It provides products for rare diseases, neurological problems, gastrointestinal (G …
  • Fonterra Co-operative Group Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Fonterra Co-operative Group Lim …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆